Contact Information

Email: komaromy@cvm.msu.edu

Phone: 517-353-5420

Fax: 517-355-5164

Veterinary Medical Center - South Building (Wings F - G)
784 Wilson RD, Room G383
East Lansing, MI 48824

Education

  • DrMedVet, University of Zurich, 1996
  • PhD, University of Florida, 2002
  • DACVO
  • DECVO

Research Interests

  • Inherited retinal diseases, therapies for retinal diseases
PubMed Research

Dr. András Komáromy’s lab is working to determine the molecular causes of inherited retinal disease in dogs and develop treatment approaches to ameliorate sight degeneration. His most recent work produced a novel gene therapy with colleague at Penn State. This ground-breaking therapy treats achromatopsia—a model cone disease—found in dogs. It is now the foundation for new studies of retinal disease in humans.

Dr. András M. Komáromy joined the College as Associate Professor in January, 2012. The Komáromy lab works to determine the molecular causes of inherited retinal diseases in dogs and develop treatment approaches to ameliorate sight degeneration.

Dr. Komáromy and colleagues from the University of Pennsylvania School of Veterinary Medicine, Temple University, University of Florida, and Cornell University developed a gene therapy to treat achromatopsia—a model cone disease—in dogs. The truly ground-breaking treatment restored cone function and is now the foundation for new studies of retinal disease in humans. Funded by grants from the National Institutes of Health, his research focuses on a new gene therapy to recover diseased cones and their function.

He is a member of the ACVO Genetics Committee and served as chair from 2004 to 2009. He has published more than 50 articles and book chapters and has been an invited speaker at national and international conferences.